Entrada Therapeutics TRDA
NASDAQ TRDA
$6.26 +0.04 (+0.64%)
At close: Sep 29, 2026 · 4:00 PM EDT

Entrada Therapeutics (TRDA) Current Assets (2020 - 2026)

Updated

Entrada Therapeutics' Current Assets was $232.7 million in Q2 2026, down 37.0% from $369.15 million a year earlier and down 12.8% from the prior quarter.

Analysis

Entrada Therapeutics (TRDA) Current Assets (2020 - 2026) Analysis & Trends

At the end of FY2025, Current Assets at Entrada Therapeutics came in at $306.25 million, down 30.4% from FY2024.

  • Current Assets shows a five-year compound annual growth rate of 50.3% (FY2020 to FY2025).
  • In earlier years, Current Assets was $440.04 million in FY2024 (+19.0%), $369.77 million in FY2023 (+76.2%), $209.88 million in FY2022 (-29.7%) and $298.7 million in FY2021 (+647.7%).
  • The Q2 2026 figure marks the lowest quarterly Current Assets since Q4 2022.
  • Compared with a year earlier, Current Assets has declined for six straight quarters, with an average decline of 14.4% over the last eight quarters.
  • The best year-over-year quarter for Current Assets over five years was Q4 2021 (growth of 647.7%); the worst was Q2 2026 (a decline of 37.0%).
  • Per Business Quant data, TRDA's Current Assets in the three quarters before Q2 2026 was $266.87 million (Q1 2026), $306.25 million (Q4 2025) and $338.26 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Entrada Therapeutics 242.19 Mn 242.19 Mn - 232.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 232.70 Mn
Mar 31, 2026 266.87 Mn
Dec 31, 2025 306.25 Mn
Sep 30, 2025 338.26 Mn
Jun 30, 2025 369.15 Mn
Mar 31, 2025 403.19 Mn
Dec 31, 2024 440.04 Mn
Sep 30, 2024 465.34 Mn
Jun 30, 2024 489.54 Mn
Mar 31, 2024 414.17 Mn
Dec 31, 2023 369.77 Mn
Sep 30, 2023 383.04 Mn
Jun 30, 2023 390.20 Mn
Mar 31, 2023 434.14 Mn
Dec 31, 2022 209.88 Mn
Sep 30, 2022 234.73 Mn
Jun 30, 2022 253.90 Mn
Mar 31, 2022 272.71 Mn
Dec 31, 2021 298.70 Mn
Sep 30, 2021 123.53 Mn
API Access

Entrada Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=TRDA&period=max&api_key=YOUR_API_KEY